Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular classification improves preoperative risk assessment of endometrial cancer.

Gynecologic oncology - 1 Oct 2024

Cabrera Silvia, Bebia Vicente, López-Gil Carlos, Luzarraga-Aznar Ana, Denizli Melek, Salazar-Huayna Lourdes, Abdessayed Nihed, Castellví Josep, Colas Eva, Gil-Moreno Antonio

Abstract excerpt

OBJECTIVE: We aimed to evaluate the performance of endometrial cancer (EC) molecular classification in predicting extrauterine disease after primary surgery alone and in combination with other clinical data available in preoperative setting. METHODS: Retrospective single-center observational study including patients with endometrial adenocarcinoma treated with primary surgery between December 1994 and May 2022....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Endometrial Neoplasms

Share to POLE gene

Share to Mutation

Share to Neoplasm Staging

Share to Risk Assessment

Source

Identifiers

PMID: 39018900
DOI: 10.1016/j.ygyno.2024.07.003

Genes

MLH1
MSH2
MSH6
PMS2
POLE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular classification improves preoperative risk assessment of endometrial cancer.PMID 39018900Read ↗

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read ↗

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read ↗

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancerSemantic proximity Read ↗

FIGO 2023 staging system with/without molecular classification vs. FIGO 2009 in 172 endometrial cancer patients.Semantic proximity Read ↗

Advantages of next-generation sequencing (NGS) in the molecular classifi cation of endometrial carcinomas - our experience with 270 cases.Semantic proximity Read ↗

Analysis of Differences in the Classification of Endometrial Cancer Patients in PolandSemantic proximity Read ↗

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer.Semantic proximity Read ↗

FIGO 2023 Staging and Molecular Classification of 172 patients with Endometrial CancerSemantic proximity Read ↗

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancerSemantic proximity Read ↗

[The influence of molecular classification in the selection of postoperative adjuvant therapy in endometrial carcinoma].Semantic proximity Read ↗

Application of novel algorithm on a retrospective series to implement the molecular classification for endometrial cancer.Semantic proximity Read ↗

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.